Sponsored Industry Symposiums

We thank our sponsors for their support of Sleep DownUnder. The schedule of Sponsored Industry Symposiums is as follows.

Attendance is complimentary, but spaces are limited so book your spot when you register for Sleep DownUnder.

Thursday 12 November

7:15am-8:15am

Eli Lilly Industry Breakfast Symposium: The Great OSA Debate: Should Incretin Therapies Redefine First-Line Management of Obesity-Related Obstructive Sleep Apnoea?

Obesity is now recognised as a primary, modifiable driver of obstructive sleep apnoea (OSA), yet CPAP remains the default first-line therapy in most clinics. With incretin-based therapies demonstrating substantial apnoea-hypopnoea index reductions in trials such as SURMOUNT-OSA, the field faces a genuine point of tension: should weight-directed pharmacotherapy be considered alongside, or even ahead of, device-based treatment for eligible patients? This breakfast symposium stages a structured debate between respiratory/sleep and endocrine perspectives, chaired by a leading sleep physician, to interrogate the evidence, the practical barriers to access, and what this shift means for multidisciplinary OSA care pathways in Australia.

Speakers:
Prof. Brendon Yee, Woolcock Institute of Medical Research / RPA Hospital, Sydney
Prof. Garun Hamilton, Director of Sleep Medicine, Monash Health; Adjunct Clinical Professor, Monash University
A/Prof. Budhima Nanayakkara, Orange Health Service / THE Lab, Orange NSW (NSW Health)

Thursday 12 November

5:15pm-6:15pm

BMC Industry Evening Symposium: Auto-CPAP Algorithms: Why Device Performance Matters

This workshop will explore how auto-CPAP devices differ in the detection and classification of respiratory events and in their pressure-response strategies. Drawing on clinical data and standardized bench testing, it will illustrate how algorithmic differences, including responses to obstructive events and unintentional leaks, can influence residual AHI estimation, delivered pressure, and therapeutic efficacy. The session will also discuss the clinical relevance of device-reported data and the importance of standardized evaluation to objectively assess and optimize auto-CPAP performance.

Speakers:
AbdelKebir Sabil

Friday 13 November

7:15am-8:15am

Phillips Industry Breakfast Symposium: Central Sleep Apnoea Management: The Latest Evidence and a Practical Clinical Guide

Central sleep apnoea (CSA) remains a complex and evolving area of sleep medicine, with advances in our understanding of pathophysiology, diagnostic approaches, and treatment options continuing to emerge. This symposium will provide clinicians with a comprehensive update on the latest evidence and guideline recommendations for CSA management, followed by a practical discussion on applying these insights in routine clinical practice. Internationally recognised sleep physician Dr Rami Khayat will review current research, recent guideline updates, and emerging therapeutic approaches. Prof Garun Hamilton will then translate the evidence into practice through real-world case studies, practical management strategies, and discussion of common challenges faced by clinicians. Together, the speakers will provide attendees with evidence-based and clinically relevant guidance to enhance the assessment and management of patients with CSA across a variety of care settings.

Speaker:
Prof Rami Khayat, Penn State Health Sleep Services, US
Prof Garun Hamilton, Monash Health and Monash University

Friday 13 November

7:15am-8:15am

Resmed Industry Breakfast Symposium: Managing the Non-Compliant OSA Patient: Optimisation, Therapy Reassessment and the Role of Bilevel Therapy

While PAP therapy remains the cornerstone of OSA management, not all patients achieve optimal outcomes with standard PAP approaches alone. This symposium will explore practical strategies for recognising patients who may require a more personalised treatment pathway, including therapy optimisation, escalation considerations, and clinical decision-making around when bilevel therapy in OSA may be appropriate. Participants will explore patient profiles, treatment pathways, and real-world scenarios where advanced PAP approaches, including VAuto therapy, may help improve comfort, adherence and long-term treatment outcomes. Through clinical discussion and real-world case studies, participants will examine how to balance efficacy, comfort, adherence and patient experience while supporting long-term treatment success. The session will also explore how connected care solutions can support patient engagement, therapy monitoring and clinical decision-making. Led by a clinical expert and supported by Resmed Medical Affairs, the symposium aims to translate clinical evidence into practical approaches that can be applied in routine patient management.

Speakers:
Dr David Michail, Sleep and Respiratory Physician, Westmead Hospital
Dr Jeff Armitstead, VP, Medical Affairs, Resmed
Ross Deas, Director, Medical Affairs, Resmed
Alisha Middleton, Senior Clinical Project Manager, Resmed

Friday 13 November

6:00pm-7:00pm

Compumedics Industry Evening Symposium: Insomnia and Multi-night Sleep Studies

This session discusses the utility of objective measures of sleep over multiple nights in assisting to understand the patient’s subjective sleep experiences related to their insomnia. Three sleep researchers/clinicians will discuss their experiences in clinical trials with using accurate, automated EEG analysis to assess sleep latency, sleep efficiency, total sleep times, wake after sleep onset, sleep-wake rhythms and integrated sleep diaries over multiple nights and how these technologies assist in diagnosis and targeting therapies to improve patient outcomes. The presentation will consider how new technologies over multiple nights can provide the opportunity to characterise insomnia, diagnose obstructive sleep apnoea (OSA), suggest possible circadian rhythm abnormalities, and influence therapy, in an efficient and cost-effective basis.
A panel discussion will follow to consider ‘is this the future of sleep diagnostics?’

Speakers:
Dr. Jeremy Goldin, Melbourne Health
Dr. Hannah Scott, Flinders University
Dr. Melissa Ree, UWA